Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.26)
# 3,330
Out of 4,774 analysts
787
Total ratings
30.03%
Success rate
-12.13%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $1.62 | +887.65% | 27 | Mar 20, 2025 | |
| XBIO Xenetic Biosciences | Reiterates: Neutral | n/a | $3.40 | - | 8 | Mar 20, 2025 | |
| PHAR Pharming Group | Reiterates: Buy | $37 | $8.93 | +314.57% | 16 | Mar 20, 2025 | |
| ATNM Actinium Pharmaceuticals | Reiterates: Buy | $4 | $1.41 | +183.69% | 25 | Mar 20, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $77 | $14.36 | +436.21% | 21 | Mar 20, 2025 | |
| XOMA XOMA Royalty | Reiterates: Buy | $104 | $21.06 | +393.83% | 22 | Mar 19, 2025 | |
| OABI OmniAb | Reiterates: Buy | $11 | $2.27 | +384.58% | 7 | Mar 19, 2025 | |
| FGEN FibroGen | Reiterates: Buy | $10 | $0.34 | +2,867.36% | 2 | Mar 18, 2025 | |
| ATYR aTyr Pharma | Reiterates: Buy | $35 | $3.76 | +830.85% | 7 | Mar 14, 2025 | |
| PDSB PDS Biotechnology | Reiterates: Buy | $21 | $1.36 | +1,444.12% | 29 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $4.27 | +626.00% | 28 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $6.37 | +151.18% | 19 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $28.35 | +259.79% | 29 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.1 | $4.06 | +0.99% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.50 | +1,700.00% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $5 | $0.65 | +663.36% | 14 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.34 | +1,076.47% | 20 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.75 | $1.68 | +242.26% | 21 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $20.37 | +179.82% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.10 | +661.90% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $19.88 | +302.41% | 31 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $221 | $188.61 | +17.17% | 27 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $3.54 | +803.95% | 27 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $43.10 | +178.42% | 45 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.85 | +409.55% | 25 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $11 | $9.35 | +17.65% | 8 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $0.76 | +821.05% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $3.93 | +1,426.72% | 16 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $5.18 | +305.41% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $2.77 | +1,344.04% | 25 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.42 | +726.45% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.63 | +217.46% | 12 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.24 | +346.43% | 16 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.01 | +248.26% | 14 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.47 | +912.15% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.28 | +557.89% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $109.41 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $170 | $7.00 | +2,328.57% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $840 → $360 | $3.42 | +10,426.32% | 11 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.70 | +1,429.41% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.16 | - | 17 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $0.81 | +5,702.47% | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $32 | $19.50 | +64.10% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $2.21 | +307.24% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.92 | +537.76% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.44 | +6,844.44% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.67 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.60 | +1,900.00% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.66 | +1,027.82% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.38 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $41.89 | -21.22% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.82 | +1,043.70% | 1 | Mar 24, 2017 |
Esperion Therapeutics
Mar 20, 2025
Reiterates: Buy
Price Target: $16
Current: $1.62
Upside: +887.65%
Xenetic Biosciences
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.40
Upside: -
Pharming Group
Mar 20, 2025
Reiterates: Buy
Price Target: $37
Current: $8.93
Upside: +314.57%
Actinium Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $4
Current: $1.41
Upside: +183.69%
Capricor Therapeutics
Mar 20, 2025
Reiterates: Buy
Price Target: $77
Current: $14.36
Upside: +436.21%
XOMA Royalty
Mar 19, 2025
Reiterates: Buy
Price Target: $104
Current: $21.06
Upside: +393.83%
OmniAb
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $2.27
Upside: +384.58%
FibroGen
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.34
Upside: +2,867.36%
aTyr Pharma
Mar 14, 2025
Reiterates: Buy
Price Target: $35
Current: $3.76
Upside: +830.85%
PDS Biotechnology
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $1.36
Upside: +1,444.12%
Mar 12, 2025
Reiterates: Buy
Price Target: $31
Current: $4.27
Upside: +626.00%
Mar 11, 2025
Reiterates: Buy
Price Target: $16
Current: $6.37
Upside: +151.18%
Mar 11, 2025
Reiterates: Buy
Price Target: $102
Current: $28.35
Upside: +259.79%
Mar 11, 2025
Downgrades: Neutral
Price Target: $4.1
Current: $4.06
Upside: +0.99%
Mar 11, 2025
Reiterates: Buy
Price Target: $9
Current: $0.50
Upside: +1,700.00%
Mar 11, 2025
Maintains: Buy
Price Target: $18 → $5
Current: $0.65
Upside: +663.36%
Mar 7, 2025
Reiterates: Buy
Price Target: $4
Current: $0.34
Upside: +1,076.47%
Mar 6, 2025
Reiterates: Buy
Price Target: $5.75
Current: $1.68
Upside: +242.26%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $20.37
Upside: +179.82%
Mar 4, 2025
Reiterates: Buy
Price Target: $16
Current: $2.10
Upside: +661.90%
Mar 3, 2025
Reiterates: Buy
Price Target: $80
Current: $19.88
Upside: +302.41%
Feb 28, 2025
Reiterates: Buy
Price Target: $221
Current: $188.61
Upside: +17.17%
Feb 28, 2025
Reiterates: Buy
Price Target: $32
Current: $3.54
Upside: +803.95%
Feb 28, 2025
Reiterates: Buy
Price Target: $120
Current: $43.10
Upside: +178.42%
Feb 27, 2025
Reiterates: Buy
Price Target: $40
Current: $7.85
Upside: +409.55%
Feb 25, 2025
Maintains: Buy
Price Target: $21 → $11
Current: $9.35
Upside: +17.65%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $0.76
Upside: +821.05%
Feb 12, 2025
Reiterates: Buy
Price Target: $60
Current: $3.93
Upside: +1,426.72%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $5.18
Upside: +305.41%
Jan 16, 2025
Reiterates: Buy
Price Target: $40
Current: $2.77
Upside: +1,344.04%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $2.42
Upside: +726.45%
Jan 10, 2025
Reiterates: Buy
Price Target: $2
Current: $0.63
Upside: +217.46%
Jan 10, 2025
Reiterates: Buy
Price Target: $10
Current: $2.24
Upside: +346.43%
Dec 19, 2024
Reiterates: Buy
Price Target: $7
Current: $2.01
Upside: +248.26%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.47
Upside: +912.15%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.28
Upside: +557.89%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $109.41
Upside: -
Dec 9, 2024
Initiates: Buy
Price Target: $170
Current: $7.00
Upside: +2,328.57%
Nov 25, 2024
Maintains: Buy
Price Target: $840 → $360
Current: $3.42
Upside: +10,426.32%
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.70
Upside: +1,429.41%
Nov 15, 2024
Reiterates: Neutral
Price Target: n/a
Current: $1.16
Upside: -
Nov 13, 2024
Reiterates: Buy
Price Target: $47
Current: $0.81
Upside: +5,702.47%
Nov 11, 2024
Maintains: Buy
Price Target: $3 → $32
Current: $19.50
Upside: +64.10%
Nov 11, 2024
Reiterates: Buy
Price Target: $9
Current: $2.21
Upside: +307.24%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.92
Upside: +537.76%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.44
Upside: +6,844.44%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.67
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.60
Upside: +1,900.00%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.66
Upside: +1,027.82%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.38
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $41.89
Upside: -21.22%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.82
Upside: +1,043.70%